A non-inferiority trial is used to test whether an antibiotic is not inferior to an existing product. Non-inferiority is confirmed if efficacy is shown to be no less than a pre-specified value, the non-inferiority margin. Determining an appropriate non-inferiority margin is challenging, and regulators have provided detailed guidance on how it should be calculated.